Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Active not recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Endometrial Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Breast Neoplasms 4Prostatic Neoplasms 3Lung Neoplasms 3Leukemia, Myeloid, Acute 3Urinary Bladder Neoplasms 2Rectal Neoplasms 2Ovarian Neoplasms 2Neoplasm Metastasis 2Leukemia, Lymphocytic, Chronic, B-Cell 2Leukemia 2Colonic Neoplasms 2Carcinoma, Intraductal, Noninfiltrating 2Vulvar Neoplasms 1Uterine Cervical Neoplasms 1Ureteral Neoplasms 1Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Smoldering Multiple Myeloma 1Small Cell Lung Carcinoma 1Skin Neoplasms 1Retinoblastoma 1Peritoneal Neoplasms 1Pathologic Complete Response 1Pancreatic Neoplasms 1Oropharyngeal Neoplasms 1Neuroblastoma 1Neoplasms 1Mouth Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 3Biopsy 2sargramostim 1gallium Ga 68 dotatate 1dinutuximab 1Watchful Waiting 1Temozolomide 1Specimen Handling 1Observation 1Isotretinoin 1Irinotecan 1High-Energy Shock Waves 1Ga(III)-DOTATOC 1Etoposide 1Doxorubicin 1Cyclophosphamide 1Colony-Stimulating Factors 1Carboplatin 13-Iodobenzylguanidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Ganglioneuroblastoma × Observation × Clear all
NCT02176967 2026-05-05

Response and Biology-Based Risk Factor-Guided Therapy in Treating Younger Patients With Non-high Risk Neuroblastoma

Children's Oncology Group

Phase 3 Active not recruiting
621 enrolled
CNS

Neuroblastoma, Ganglioneuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡